DashboardForm 483sForm 483 Details

Gemini Pharmaceuticals, Inc. Form 483 Details

Form 483
View FDA's record for this firm
Source: FDA inspection recordConfirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months.

To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 2432926.

Gemini Pharmaceuticals, Inc.

Commack, New York, United States
Issue DateJune 30, 2015
FEI Number2432926
CountryUnited States
Status
No Warning Letter
Product Type
Drugs
Gemini Pharmaceuticals, Inc. FDA Form 483, Commack, New York, June 30, 2015